The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 3 PLT and PMI (measured at admission, day 2, and day 7) multivariate analysis based on 12-month survival status additionally adjusted for age, diabetes, hypertension, Hb, and sPO₂ using Repeated Measures GLM: Contribution of potential confounders to within-samples variability

From: The day after intracerebral hemorrhage: platelet mass index as predictor of survival—a retrospective cohort study

Parameters	PLT			PMI
Parameters	Admission	Day 2	Day 7	Admission	Day 2	Day 7
Gender	0.071	0.244	0.314	0.069	0.251	0.311
CAD	0.905	0.546	0.770	0.694	0.416	0.582
Dyslipidemia	0.399	0.033	0.219	0.383	0.030	0.192
Antiplatelets	0.639	0.445	0.609	0.489	0.402	0.451
Anticoagulants	0.297	0.253	0.534	0.275	0.172	0.120
Admission time	0.323	0.974	0.476	0.350	0.953	0.855
Glucose	0.016	0.031	0.003	0.017	0.018	0.005
Potassium	0.957	0.954	0.136	0.915	0.883	0.132
Sodium	0.519	0.860	0.574	0.429	0.967	0.395
BUN	0.487	0.388	0.550	0.605	0.762	0.642
Creatinine	0.169	0.099	0.163	0.250	0.257	0.190
pH	0.399	0.764	0.110	0.664	0.889	0.098
Bicarbonates	0.674	0.739	0.793	0.559	0.521	0.797
Lactates	0.030	0.049	0.323	0.022	0.068	0.440
CRP	0.205	0.655	0.508	0.215	0.567	0.492
Temperature	0.205	0.021	0.309	0.338	0.058	0.751
SBP	0.757	0.802	0.470	0.996	0.454	0.647
DBP	0.583	0.842	0.363	0.729	0.874	0.513
Pulse rate	0.989	0.201	0.907	0.917	0.132	0.741

Bold vaues correspond to statistcally significant p-values

Back to article page